exploit
cross
passiv
immunotherapi
enterovirusinduc
handfootandmouth
diseas
hfmd
cross
antivir
activ
neutral
antibodi
enteroviru
coxsackieviru
investig
vitro
white
leghorn
specificpathogenfre
chicken
immun
antigen
specif
isol
immunoglobulin
igi
prepar
chicken
egg
yolk
igi
purifi
character
sdspage
elisa
western
blot
bidirect
immun
agar
diffus
test
antivir
activ
doserespons
igi
determin
assess
cytopath
effect
rhabdomyosarcoma
rd
cell
vitro
indic
level
igi
increas
day
peak
week
maintain
higher
level
week
follow
immun
compar
neg
control
result
western
blot
bidirect
immun
agar
diffus
test
reveal
igi
crossbind
properti
strain
target
envelop
protein
neutral
assay
result
indic
infect
strain
rd
cell
crossblock
igi
dosedepend
manner
conclud
find
indic
igi
cross
antivir
activ
vitro
could
potenti
develop
passiv
immunotherapi
hfmd
handfootandmouth
diseas
hfmd
infantil
diseas
character
herp
hand
feet
mouth
associ
neurolog
syndrom
major
virus
caus
hfmd
hfmd
seriou
two
caus
neurolog
syndrom
central
nervou
system
may
lead
mortal
hfmd
usual
lead
milder
symptom
morbid
mortal
lower
compar
hfmd
howev
major
caus
hfmd
outbreak
zhu
et
al
conduct
followup
patient
clinic
confirm
hfmd
reveal
case
identifi
hfmd
case
hfmd
case
caus
enterovirus
case
associ
enteroviru
furthermor
patient
sever
fatal
hfmd
report
unit
state
franc
japan
china
experiment
treatment
hfmd
includ
inactiv
viru
vaccin
dna
vaccin
synthet
peptid
vaccin
recombin
vaccin
live
attenu
vaccin
neutral
antibodi
antivir
compound
inspir
previou
inactiv
polio
vaccin
develop
activ
immunoassay
inactiv
vaccin
make
rapid
progress
decemb
china
food
drug
administr
approv
two
inactiv
vaccin
prevent
sever
hfmd
vaccin
present
develop
china
howev
vaccin
provid
protect
hfmd
caus
singl
enteroviru
clinic
symptom
hfmd
caus
strain
indistinguish
may
caus
outbreak
altern
simultan
asian
countri
recombin
viral
gene
produc
novel
viral
variant
largescal
outbreak
hfmd
caus
recombin
viru
occur
citi
fuyang
china
therefor
necessari
develop
effect
therapeut
agent
therapi
treatment
hfmd
passiv
immun
intraven
inject
human
immunoglobulin
wide
use
provid
immunolog
protect
passiv
immun
immunocompromis
individu
howev
therapeut
efficaci
unstabl
risk
advers
drug
effect
high
monoclon
antibodi
produc
hybridoma
cell
anoth
form
passiv
immun
effect
howev
antibodi
inject
human
immun
reject
typic
occur
immunoglobulin
igi
extract
egg
yolk
immun
poultri
excel
antibodi
sourc
passiv
immun
compar
igg
mammal
igi
stabl
easi
collect
high
yield
react
rheumatoid
factor
complement
compon
mammalian
fc
receptor
human
serum
present
applic
igi
diagnosi
treatment
human
diseas
becom
research
hotspot
particularli
regard
infect
caus
helicobact
pylori
vibrio
cholera
bacteri
infect
well
infect
human
rotaviru
sever
acut
respiratori
syndrom
coronaviru
virus
igi
also
use
prepar
diagnost
antibodi
immunohistochemistri
elisa
western
blot
diagnost
techniqu
present
studi
cross
antivir
activ
igi
assess
white
leghorn
specificpathogenfre
bwelspf
chicken
immun
inactiv
strain
specif
igi
prepar
egg
yolk
inhibitori
activ
igi
strain
indic
vitro
furthermor
puriti
titer
igi
determin
sdspage
indirect
elisa
western
blot
longterm
aim
present
project
develop
specif
igi
could
potenti
act
antivir
agent
crosspass
immunotherapi
hfmd
cell
virus
rhabdomyosarcoma
rd
cell
obtain
china
center
type
cultur
collect
wuhan
china
coxsackieviru
coxsackieviru
coxsackieviru
coxsackieviru
coxsackieviru
coxsackieviru
purchas
state
key
laboratori
virolog
wuhan
china
dilut
dulbecco
modifi
eagl
medium
dmem
gibco
thermo
fisher
scientif
inc
waltham
usa
supplement
fetal
bovin
serum
fb
corn
inc
corn
ny
usa
uml
penicillin
sigmaaldrich
merck
kgaa
darmstadt
germani
streptomycin
sigmaaldrich
merck
kgaa
rd
cell
cultur
viruscontain
medium
co
humidifi
incub
rd
cell
contain
virus
reach
confluenc
cell
frozenthaw
centrifug
x
g
min
filter
filter
storag
chicken
immun
total
singlecomb
bwelspf
chicken
purchas
spf
experiment
anim
center
guangdong
emerg
dahua
agricultur
poultri
co
ltd
guangzhou
china
chicken
rais
superclean
bench
suzhou
antai
airtech
co
ltd
suzhou
china
access
food
water
ph
week
lay
chicken
divid
two
group
group
group
b
mix
antigen
tcid
ml
equal
amount
freund
incomplet
adjuv
fulli
emulsifi
chicken
randomli
select
group
inject
intramuscularli
side
chicken
wing
left
right
side
breast
mlsite
group
b
chicken
given
mixtur
ml
salin
freund
incomplet
adjuv
mlsite
group
b
inject
perform
onceweek
week
egg
collect
day
label
store
chicken
euthan
week
follow
first
immun
isol
purif
igi
chicken
egg
yolk
fresh
egg
clean
alcohol
cotton
ball
egg
yolk
separ
extra
albumen
roll
filter
paper
egg
yolk
without
membran
dilut
cold
deioniz
water
mix
adjust
ph
mol
hcl
store
overnight
solut
centrifug
x
g
min
supernat
ad
ammonium
sulphat
make
final
satur
follow
solut
incub
h
centrifug
x
g
min
supernat
discard
deioniz
water
time
volum
egg
yolk
without
membran
use
dissolv
protein
precipit
subsequ
sodium
sulfat
ad
make
final
mass
fraction
mixtur
incub
h
centrifug
condit
sediment
dissolv
phosphatebuff
salin
pb
solut
dialyz
h
water
chang
everi
hour
soak
pb
overnight
store
igi
purifi
egg
group
immun
specif
igi
sigi
group
b
neg
control
igi
cigi
purifi
igi
subject
centrifug
ultrafiltr
x
g
min
use
amicon
centrifug
filter
unit
emd
millipor
billerica
usa
desalt
concentr
antibodi
purifi
igi
use
subsequ
vitro
neutral
assay
western
blot
quantit
purfi
igi
antibodi
titer
sigi
cigi
purifi
igi
determin
use
indirect
elisa
purifi
igi
egg
yolk
dilut
pb
ad
elisa
plate
coat
purifi
antigen
three
duplic
well
set
sampl
cigi
group
sigi
group
plate
cover
incub
min
well
wash
time
min
time
wash
buffer
provid
ab
elisa
kit
cat
nanj
senbeijia
biolog
technolog
co
ltd
nanj
china
plate
incub
horseradish
peroxidas
hrp
conjug
goat
antichicken
igi
antibodi
abcam
cambridg
usa
min
wash
time
wash
buffer
sec
time
subsequ
incub
freshli
prepar
tmb
color
liquid
color
liquid
b
dark
min
follow
color
develop
mol
h
ad
stop
reaction
absorb
measur
immedi
nm
use
biotek
el
micropl
reader
omega
biotek
inc
norcross
ga
usa
concentr
igi
obtain
accord
standard
curv
sampl
igi
load
buffer
heat
metal
water
bath
min
place
ice
addit
min
sampl
separ
via
sdspage
gel
constant
current
min
follow
protein
separ
gel
stain
coomassi
brilliant
blue
min
destain
destain
solut
min
time
coomassiestain
gel
imag
protein
band
analyz
use
bandscan
softwar
prozym
hayward
ca
usa
western
blot
total
protein
purifi
viru
strain
vaccin
cat
creativ
diagnost
co
new
york
ny
usa
quantifi
use
bicinchonin
acid
assay
thermo
fisher
scientif
inc
load
buffer
cat
beyotim
institut
biotechnolog
haimen
china
ad
sampl
denatur
heat
metal
water
bath
min
sampl
place
ice
min
sampl
proteinlan
separ
via
sdspage
gel
separ
protein
transfer
onto
polyvinyliden
fluorid
membran
block
skim
milk
room
temperatur
min
membran
wash
five
time
trisbuff
salin
contain
tbst
membran
incub
primari
antibodi
overnight
shake
incub
membran
wash
five
time
tbst
follow
primari
incub
membran
incub
secondari
antibodi
min
shake
incub
room
temperatur
wash
four
time
tbst
primari
secondari
antibodi
use
summar
tabl
protein
band
visual
use
enhanc
chemiluminesc
western
blot
kit
thermo
fisher
scientif
inc
bidirect
immun
agar
diffus
test
gl
agaros
plate
prepar
plumshap
hole
apertur
mm
hole
distanc
mm
punch
agaros
plate
inactiv
viru
ad
central
well
differ
dilut
purifi
igi
ad
peripher
well
time
blank
group
pb
also
assess
follow
plate
place
upsid
box
incub
h
format
precipit
line
observ
tissu
cultur
infect
dose
tcid
assay
viru
strain
serial
dilut
dmem
supplement
fb
titrat
rd
monolay
cell
seed
plate
densiti
cellswel
virusinfect
cell
incub
h
co
humidifi
incub
presenc
cytopath
effect
cpe
observ
microscop
olympu
corpor
tokyo
japan
tcid
viru
strain
determin
accord
reedmuench
formula
vitro
neutral
assay
rd
cell
seed
plate
concentr
well
cultur
overnight
sigi
cigi
dilut
mgml
pb
enviroxim
puriti
toronto
research
chemic
inc
north
york
canada
dissolv
dimethyl
sulfoxid
mgml
dilut
cultur
media
experi
divid
group
blank
control
group
pb
neg
control
igi
cigi
sigi
group
envrioxim
group
subsequ
sigi
cigi
incub
min
sigi
cigi
enviroxim
serial
dilut
cultur
media
mix
equal
volum
tcid
mixtur
shaken
min
incub
co
humidifi
incub
min
subsequ
rd
cell
inocul
mixtur
incub
co
humidifi
incub
h
promot
antibodi
bind
virus
neutral
titer
determin
highest
dilut
antibodi
protect
least
half
rd
cell
one
well
cpe
detect
antivir
activ
igi
differ
enterovirus
sigi
cigi
monoclon
antibodi
tabl
ii
incub
min
antibodi
dilut
mix
equal
volum
tcid
strain
respect
oscil
incub
perform
mention
inhibit
rate
base
cpe
determin
stabil
purifi
igi
differ
physic
condit
igi
dilut
mgml
pb
dilut
igi
incub
differ
temperatur
room
temperatur
h
frozenthaw
frozen
thaw
five
time
serial
dilut
igi
mix
equal
volum
strain
tcid
experi
divid
group
group
room
temperatur
rt
group
group
group
freezethaw
group
follow
oscil
incub
calcul
inhibit
rate
perform
describ
determin
timedepend
effect
purifi
igi
infect
rd
cell
sigi
cigi
dilut
mgml
pb
incub
min
cultur
supernat
rd
cell
plate
replac
strain
tcid
total
igi
ad
rd
cell
h
postinfect
rd
cell
incub
co
h
cell
cultur
inhibit
rate
rd
cell
obtain
accord
cpe
statist
data
analysi
data
present
mean
standard
deviat
statist
analysi
perform
use
graphpad
prism
softwar
version
graphpad
softwar
la
jolla
ca
usa
spss
softwar
ibm
corp
armonk
ny
usa
student
ttest
use
evalu
differ
two
group
oneway
analysi
varianc
follow
dunnett
post
hoc
test
use
evalu
differ
among
differ
group
p
consid
indic
statist
signific
differ
present
studi
perform
isol
purifi
sigi
chicken
egg
yolk
indic
fig
level
sigi
detect
day
peak
week
maintain
higher
level
compar
cigi
total
week
level
sigi
began
decreas
gradual
week
follow
initi
immun
wherea
level
cigi
group
chang
significantli
experiment
period
suggest
isol
igi
specif
respons
immun
furthermor
level
igi
group
group
b
chicken
egg
yolk
elev
immun
tabl
ii
find
conclud
sigi
week
chicken
egg
yolk
antigen
immun
would
purifi
use
follow
experi
character
isol
igi
titer
virus
determin
use
tcid
assay
result
indic
tcid
strain
tcid
ml
wherea
tcid
strain
tcid
ml
indic
fig
result
sdspage
demonstr
disulfid
bond
target
protein
open
reduct
condit
presenc
two
domin
band
speci
repres
h
chain
speci
correspond
l
chain
note
watersolubl
fraction
wsf
contain
larg
amount
heteroprotein
egg
yolk
acidisol
water
use
dissolv
egg
yolk
salt
twice
satur
nh
mass
fraction
na
markedli
improv
puriti
igi
howev
sdspage
result
indic
impur
band
still
present
sampl
may
includ
low
densiti
lipoprotein
activ
protein
puriti
igi
determin
accord
gel
system
softwar
bandscan
igi
cross
bind
structur
protein
titer
purifi
igi
measur
bidirect
immun
agar
diffus
test
indic
fig
b
white
precipit
line
identifi
antigen
hole
center
antibodi
well
dilut
ratio
precipit
line
indic
pb
well
antigen
well
data
suggest
purifi
sigi
abil
specif
cross
bind
antigen
result
western
blot
confirm
sigi
exhibit
good
immunolog
bind
reaction
viral
protein
wherea
neither
immunoreact
cigi
fig
suggest
purifi
igi
specif
recogn
protein
strain
protein
virus
sampl
identifi
kda
kda
predict
molecular
weight
protein
kda
kda
protein
verifi
monoclon
antibodi
fig
lane
purifi
igi
verifi
commerci
protein
fig
taken
togeth
data
indic
igi
isol
egg
yolk
bwelspf
chicken
specif
cross
bind
virus
data
consist
result
elisa
abil
antibodi
inhibit
cpe
determin
use
neutral
assay
cpe
valu
express
rel
cell
antibodi
treatment
control
cpe
valu
data
present
mean
standard
deviat
three
independ
experi
p
p
p
vs
cigi
rd
rhabdomyosarcoma
igi
immunoglobulin
enteroviru
coxsackieviru
cigi
neg
control
igi
sigi
specif
igi
cpe
cytopath
effect
protect
effect
purifi
igi
enterovirusinduc
cpe
rd
cell
assess
neutral
assay
vitro
indic
fig
rd
cell
noninfect
group
normal
healthi
indic
igi
posit
control
drug
envrioxim
cytotox
effect
rd
cell
cell
infect
strain
differ
degre
cpe
atrophi
round
shed
apoptosi
appear
blank
control
group
cigi
group
envrioxim
group
wherea
rd
cell
exhibit
cpe
sigi
group
suggest
protect
effect
specif
igi
infect
rd
cell
fig
fig
indic
igi
strong
activ
vitro
concentr
result
fig
reveal
igi
strong
activ
vitro
concentr
substanti
inhibit
cpe
block
infect
viru
howev
lower
concentr
igi
prevent
viru
infect
rd
cell
understand
timedepend
protect
sigi
enteroviru
infect
rd
cell
infect
igi
ad
cell
differ
time
point
infect
present
data
indic
igi
inhibit
cpe
rd
cell
igi
ad
h
postinfect
inhibit
cpe
igi
ad
h
postinfect
fig
stabil
antivir
activ
determin
isol
igi
observ
fig
purifi
igi
stabl
h
room
temperatur
inhibit
rate
almost
cell
treat
igi
h
furthermor
decreas
antivir
activ
observ
sigi
rd
cell
infect
treat
igi
follow
exposur
igi
differ
temperatur
h
freezingthaw
five
time
cpe
valu
express
rel
cell
antibodi
treatment
control
cpe
valu
p
p
vs
rt
igi
c
inhibitori
effect
sigi
cpe
induc
differ
enteroviru
strain
rd
cell
infect
eight
differ
enteroviru
strain
cell
treat
cigi
sigi
mab
cpe
valu
express
rel
cell
antibodi
treatment
control
cpe
valu
data
present
mean
standard
deviat
three
independ
experi
p
p
indic
mab
igi
monoclon
antibodi
rd
rhabdomyosarcoma
igi
immunoglobulin
enteroviru
cigi
neg
control
igi
sigi
specif
igi
cpe
cytopath
effect
freez
thaw
five
time
fig
indic
freezethaw
cycl
impair
igi
activ
antivir
activ
purifi
igi
differ
strain
enteroviru
demonstr
sigi
strong
inhibitori
activ
strain
p
margin
antivir
activ
strain
enteroviru
examin
includ
fig
result
reveal
sigi
differenti
antivir
activ
among
differ
type
enteroviru
suggest
igi
isol
chicken
egg
yolk
specif
protect
infect
belong
small
rna
famili
enteroviru
genu
approxim
structur
four
structur
protein
locat
insid
capsid
connect
rna
locat
surfac
capsid
cleav
protein
autocatalyt
action
involv
virion
stabil
infect
previou
find
suggest
antigen
determin
base
surfac
protein
treatment
hfmd
inactiv
viru
vaccin
prove
immunogen
cross
protect
entericvirus
phase
iii
clinic
trial
lim
et
al
screen
monoclon
antibodi
recogn
ntermin
passiv
immun
studi
demonstr
crossneutr
monoclon
antibodi
multipl
subtyp
strain
howev
effect
strain
present
studi
result
neutral
assay
reveal
sigi
cross
block
cpe
induc
dosedepend
manner
vitro
furthermor
bidirect
immun
agar
diffus
test
western
blot
demonstr
isol
igi
cross
bound
envelop
protein
suggest
inhibitori
effect
igi
cpe
mediat
target
structur
protein
therefor
conclud
isol
igi
like
effect
recogn
sequenti
epitop
conform
structur
prevent
enter
infect
host
cell
ultim
prevent
treat
infect
notabl
chicken
antibodi
may
recogn
sequenti
epitop
conform
structur
igi
sum
antibodi
extract
egg
yolk
immun
bwelspf
chicken
antigen
specif
present
studi
mg
igi
extract
egg
notabl
total
igi
produc
immun
chicken
year
time
much
igg
produc
immun
rabbit
protein
egg
yolk
predominantli
divid
wsf
waterinsolubl
fraction
present
studi
result
indic
level
igi
egg
yolk
significantli
increas
follow
immun
may
due
increas
age
chicken
sdspage
result
reveal
purifi
igi
compos
h
chain
l
chain
consist
literatur
suggest
igi
antibodi
high
puriti
obtain
water
dilut
combin
sulfat
precipit
indirect
elisa
measur
sigi
titer
growthdeclin
rule
indic
titer
antibodi
peak
week
initi
immun
maintain
higher
level
week
compar
cigi
antibodi
level
decreas
gradual
week
high
titer
suitabl
puriti
long
durat
igi
immun
egg
yolk
make
possibl
manufactur
plant
prepar
larg
quantiti
igi
conclus
present
find
indic
level
sigi
significantli
increas
chicken
egg
yolk
follow
immun
also
reveal
igi
cross
block
cpe
induc
igi
cross
bound
envelop
protein
suggest
cross
protect
igi
infect
may
mediat
target
structur
protein
two
virus
find
provid
scientif
basi
develop
igi
cross
passiv
immunotherapi
hfmd
vivo
studi
preclin
anim
model
cross
immunotherapi
warrant
